|
|
National Research Corporation (NRC) |
|
|
|
National Research's Yearly Income from Continued Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
|
NRC Annual Income from Cont. Operations Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
Y / Y Annual Income from Cont. Operations Change |
-2.61 % |
-15.12 % |
0.55 % |
14.98 % |
7.85 % |
Annual Income from Cont. Operations (in millions $) |
$30.97 |
$31.80 |
$37.47 |
$37.26 |
$32.41 |
Annual Income from Cont. Operations Growth
Comment |
National Research Corporation experienced detoriation of Annual Income from Cont. Operations for the fiscal year ended 2023 by -2.61% to $ 30.97 millions, compare to $ 31.80 in Annual Income from Cont. Operations reported in the previous year. National Research's Income from Continued Operations decline slowed form -15.12 % contraction in the fiscal year 2022.
National Research Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Income from Cont. Operations within Healthcare Sector | Y/Y Income from Continued Operations Growth % | 2023 Annual Income from Cont. Operations | Viatris Inc | -97.37 % | $ 54.700 millions | Revvity Inc | -64.99 % | $ 179.503 millions | Catalent Inc | | | |